ArticleThe Journal of biological chemistry2016

Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.

Shweta Pasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.